ES358534A2 - Procedimiento para la fabricacion de derivados de alcanolamina - Google Patents

Procedimiento para la fabricacion de derivados de alcanolamina

Info

Publication number
ES358534A2
ES358534A2 ES358534A ES358534A ES358534A2 ES 358534 A2 ES358534 A2 ES 358534A2 ES 358534 A ES358534 A ES 358534A ES 358534 A ES358534 A ES 358534A ES 358534 A2 ES358534 A2 ES 358534A2
Authority
ES
Spain
Prior art keywords
radical
carbon atoms
radicals
atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES358534A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES358534A2 publication Critical patent/ES358534A2/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
ES358534A 1964-09-30 1968-09-16 Procedimiento para la fabricacion de derivados de alcanolamina Expired ES358534A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB39774/64A GB1078852A (en) 1964-09-30 1964-09-30 Alkanolamine derivatives
ES0318019A ES318019A1 (es) 1964-09-30 1965-09-30 Procedimiento para la fabricaciën de derivados de alcanolamina

Publications (1)

Publication Number Publication Date
ES358534A2 true ES358534A2 (es) 1970-07-01

Family

ID=10411417

Family Applications (2)

Application Number Title Priority Date Filing Date
ES0318019A Expired ES318019A1 (es) 1964-09-30 1965-09-30 Procedimiento para la fabricaciën de derivados de alcanolamina
ES358534A Expired ES358534A2 (es) 1964-09-30 1968-09-16 Procedimiento para la fabricacion de derivados de alcanolamina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES0318019A Expired ES318019A1 (es) 1964-09-30 1965-09-30 Procedimiento para la fabricaciën de derivados de alcanolamina

Country Status (13)

Country Link
US (1) US3408387A (es)
JP (2) JPS5031136B1 (es)
AT (2) AT261586B (es)
BE (1) BE670364A (es)
BR (1) BR6573584D0 (es)
CH (1) CH504407A (es)
DE (1) DE1493887C3 (es)
DK (2) DK113295B (es)
ES (2) ES318019A1 (es)
FR (1) FR5662M (es)
GB (1) GB1078852A (es)
NL (1) NL6512676A (es)
SE (1) SE313061B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857952A (en) * 1967-12-22 1974-12-31 May & Baker Ltd Certain benzene derivatives useful in treating cardiac disorders
ZA6808345B (en) * 1967-12-22 May & Baker Ltd Benzene derivatives
GB1269775A (en) * 1968-07-18 1972-04-06 Ici Ltd Alkanolamine derivatives
CA957364A (en) * 1968-11-18 1974-11-05 Pfizer Corporation Preparation of polar-substituted phenyl propanolamines
US3934032A (en) * 1969-02-21 1976-01-20 Imperial Chemical Industries Limited Alkanolamine derivatives for treating hypertension
US3873618A (en) * 1969-07-18 1975-03-25 Ici Ltd 1-{8 4-(4-Acetamidophenyl)phenoxy{9 -3-isopropyl-2-propanol
US4120978A (en) * 1970-01-08 1978-10-17 Ciba-Geigy Corporation Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US3864398A (en) * 1972-05-01 1975-02-04 Teikoku Hormone Mfg Co Ltd Process for the preparation of acylamino alkanol derivatives
JPS5323826B2 (es) * 1972-05-15 1978-07-17
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4064125A (en) * 1976-10-29 1977-12-20 E. R. Squibb And Sons, Inc. Substituted amides having antiinflammatory activity
US4177280A (en) * 1978-07-03 1979-12-04 Syntex (U.S.A.) Inc. Bicyclo[3.1.0]hexyl-substituted carbonylaminophenoxy cardiovascular agents
DE2948056A1 (de) * 1979-11-29 1981-06-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
DE3640829A1 (de) * 1986-11-28 1988-06-09 Boehringer Ingelheim Kg Neue 1-aryloxy-3-amino-2-propanole, ihre herstellung und verwendung
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055A (zh) 2019-01-18 2021-10-29 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB922600A (en) * 1960-05-06 1963-04-03 Crookes Lab Ltd Ortho-tertiary-butyl phenolethers

Also Published As

Publication number Publication date
AT261582B (de) 1968-05-10
DE1493887B2 (de) 1977-08-25
DE1493887C3 (de) 1978-06-15
CH504407A (de) 1971-03-15
JPS5031136B1 (es) 1975-10-07
JPS514978B1 (es) 1976-02-16
BE670364A (es) 1966-03-30
NL6512676A (es) 1966-03-31
DK113295B (da) 1969-03-10
AT261586B (de) 1968-05-10
SE313061B (es) 1969-08-04
ES318019A1 (es) 1966-07-01
DK122879B (da) 1972-04-24
US3408387A (en) 1968-10-29
GB1078852A (en) 1967-08-09
FR5662M (es) 1968-01-02
DE1493887A1 (de) 1972-06-15
BR6573584D0 (pt) 1973-08-02

Similar Documents

Publication Publication Date Title
ES358534A2 (es) Procedimiento para la fabricacion de derivados de alcanolamina
ES462061A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
GB961037A (en) Pyrazolones and processes for their preparation
ES393496A1 (es) Procedimiento de preparacion de nuevos derivados de la 2-pi-rrolidinonas.
DK439384D0 (da) Derivater af 4-(3-alkynyloxy-2-hydroxypropyl)-piperazin-1-yl-n-phenylacetamid, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
ES365102A1 (es) Un metodo para preparar composiciones farmaceuticas a base de nuevas benzotriazinonas.
ES333487A1 (es) Procedimiento para la preparacion de nuevos derivados de urea sustituidos.
SE425395B (sv) Forfarande for framstellning av fenyl- eller bensylfosfonatestrar
ES330229A1 (es) Procedimiento para la fabricacion de derivados quinolinos de efecto veterinario.
PT78375B (en) Process for the preparation of n-sulphenylated phenethylsulphonamides with fungicidal effects
ES455532A1 (es) Procedimiento para la preparacion de triazapentadienos.
ES324510A1 (es) Procedimiento para la polimerizacion de compuestos organicos no saturados.
ES417018A1 (es) Un procedimiento para la preparacion de un compuesto delta 2-1,2,4-triazolin-1 o 4-il-metilfosforoso.
ES296162A1 (es) Procedimiento para la preparaciën de nuevas hidrazonas de 5-nitro-furfurol
ES364725A1 (es) Procedimiento para la preparacion de nuevos derivados de p-aminoalquil-bencensulfonamida.
ES458021A1 (es) Procedimiento para la obtencion de derivados de acido pros- tanoico.
ES258215A1 (es) Proceso para la preparaciën de penicilina de la fërmula general: y sales atëxicas de las mismas
ES433039A3 (es) Procedimiento de preparacion de derivados tiazolinicos y-o tiazoles.
GB1093912A (en) Pseudo-indole derivatives
ES302872A1 (es) Un procedimiento de preparacion de 3-dialcoilaminoalcoxi-indazoles sustituidos en posicion i.
ES455953A1 (es) Procedimiento para la obtencion de amidas de acido 2,3-dihi-dro-1-benzotiepin-4-carboxilico.
ES324047A1 (es) Procedimiento para la sintesis de 7-triacinilaminocumarinas.
ES320802A1 (es) Un procedimiento para la preparaciën de 2- (2'-tiazolin-2'- i1) -bencimidazoles
ES331822A1 (es) Un procedimiento para la preparacion de nuevos compuestos nitrogenados, en especial con accion espasmolitica.
ES317464A1 (es) Procedimiento para la fabricaciën de nuevos derivados de la fenotiazina